Phase 2 Study to Evaluate Safety and Pharmacodynamics of CS-3150 in Type 2 Diabetes Mellitus Patients with Albuminuria
Phase 2
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- JPRN-jRCT2080221972
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Main Inclusion Criteria;
-A diagnosis of Type 2 Diabetes Mellitus with Albuminuria
-Male and Female of 30 to 70 years of age
-Complication of Hypertension
Exclusion Criteria
Main Exclusion Criteria;
-Type 1 Diabetes Mellitus
-Patients with known Non-Diabetic Renal Disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method